OMICS International https://www.omicsonline.org/ OMICS International is a scientific organization that drives the progress of research through open access journals and organizes international conferences, The best in science news, commentary, and research. https://www.omicsonline.org/ArchiveJCM/currentissue-carcinogenesis-mutagenesis-open-access.php Journal of Carcinogenesis & Mutagenesis Volume 8, Issue 3 https://www.omicsonline.org/open-access/development-of-anticancer-stem-cells-as-theranostic-agents-in-the-treatment-of-different-cancer-types--an-update-2157-2518-1000291.php?aid=89751 Development of AntiCancer Stem Cells as Theranostic Agents in the Treatment of Different Cancer Types An Update Arif Malik, Rabia Rasool, Saima Rubab Khan, Sulayman Waquar, Javed Iqbal, Syed Saeed Ul Hassan, Mahmood Husain Qazi and Aamer Qazi https://www.omicsonline.org/open-access/characterization-of-a-novel-cell-line-hch3-derived-from-a-human-ovarian-clear-cell-carcinoma-2157-2518-1000292.php?aid=89752 Characterization of a Novel Cell Line HCH3 Derived from a Human Ovarian Clear Cell Carcinoma Takashi Yamada, Kimiaki Hattori, Hidetoshi Satomi, Tadashi Okazaki, Hiroshi Mori and Yoshinobu Hirose https://www.omicsonline.org/open-access/risk-of-prostate-cancer-and-cyclin-d1-a870g-polymorphism-a-study-of-correlation-2157-2518-1000293.php?aid=89121 Risk of Prostate Cancer and Cyclin D1 A870G polymorphism a Study of Correlation Firdous Hussain, Arif Hamid, and Rita Singh Majumdhar https://www.omicsonline.org/open-access/soluble-epoxide-hydrolase-potential-target-for-inflammation-and-inflammationdriven-cancer-2157-2518-1000294.php?aid=89753 Soluble Epoxide Hydrolase Potential Target for Inflammation and InflammationDriven Cancer Chao Lou, Liping Zhang, Xiaobing Wang, Xiaoping Ma, Cuiyun Qin, Wei Li, Ting Jia, Qing Nan and Rong Qiang https://www.omicsonline.org/open-access/use-of-e18-cell-model-to-quantify-dna-strand-break-associated-bystander-effect-dsbabe-2157-2518-1000295.php?aid=89754 Use of E18 Cell Model to Quantify DNA Strand Break Associated Bystander Effect DSBABE Jalal Nasir https://www.omicsonline.org/open-access/oxaliplatin-plus-s1-for-treating-sorafenibrefractory-recurrent-hepatocellular-carcinoma-after-liver-transplantation-2157-2518-1000296.php?aid=89755 Oxaliplatin Plus S1 for Treating SorafenibRefractory Recurrent Hepatocellular Carcinoma after Liver Transplantation Jing Sun, Xiaomin Cai, Wei Li, Meiling Zhang, Jing He, Qian Wang and Kaihua Lu